Literature DB >> 28315279

The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma.

Barbara Mysona1, Neil Kansara2,3, Jing Zhao3,4, Kathryn Bollinger5,6,7,8.   

Abstract

The role of sigma 1 receptor (S1R) in glaucoma is emerging as a promising field of study. Glaucoma is an optic neuropathy that shares common pathogenic mechanisms with other neurodegenerative diseases such as Alzheimer's and Parkinson's disease . S1R modulates multiple cellular functions associated with neurodegeneration . These include Ca2+ ion homeostasis, endoplasmic reticulum (ER) and oxidative stress , survival signaling pathways, neurotrophin secretion, and glial activation. S1R may also have neurorestorative properties including enhancement of neuronal plasticity and neurite outgrowth. Recent studies using agonists for S1R within the eye provide hope that it could be a therapeutic target for glaucoma. Understanding the role of S1R in glaucoma may help us to stop the progression of this sight threatening disease.

Entities:  

Keywords:  Glaucoma; Neurodegeneration; Neuroprotection; Optic nerve; Retinal ganglion cell

Mesh:

Substances:

Year:  2017        PMID: 28315279     DOI: 10.1007/978-3-319-50174-1_20

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma.

Authors:  Michal Geva; Noga Gershoni-Emek; Luana Naia; Philip Ly; Sandra Mota; Ana Cristina Rego; Michael R Hayden; Leonard A Levin
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

Review 2.  Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms.

Authors:  Zifen Xu; Yushuang Lei; Huan Qin; Shiyao Zhang; Ping Li; Kai Yao
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.